Search

John Matthew Mauro

Examiner (ID: 6494, Phone: (571)272-6070 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1622, 1625
Total Applications
896
Issued Applications
752
Pending Applications
0
Abandoned Applications
151

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12205772 [patent_doc_number] => 20180050999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-22 [patent_title] => 'PROCESSES AND INTERMEDIATES FOR THE PREPARATIONS OF ISOMER FREE PROSTAGLANDINS' [patent_app_type] => utility [patent_app_number] => 15/796324 [patent_app_country] => US [patent_app_date] => 2017-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27043 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15796324 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/796324
Processes and intermediates for the preparations of isomer free prostaglandins Oct 26, 2017 Issued
Array ( [id] => 12185349 [patent_doc_number] => 20180044285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-15 [patent_title] => 'METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF OREXIN-2 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 15/791814 [patent_app_country] => US [patent_app_date] => 2017-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19579 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15791814 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/791814
METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF OREXIN-2 RECEPTOR ANTAGONISTS Oct 23, 2017 Abandoned
Array ( [id] => 14341927 [patent_doc_number] => 20190152936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => METHOD FOR PREPARING 2,5-DIMETHYLFURAN BY DIRECTLY CATALYZING CARBOHYDRATE USING MODIFIED PD/C [patent_app_type] => utility [patent_app_number] => 16/313203 [patent_app_country] => US [patent_app_date] => 2017-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3559 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313203 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/313203
Method for preparing 2,5-dimethylfuran by directly catalyzing carbohydrate using modified Pd/C Oct 11, 2017 Issued
Array ( [id] => 12997629 [patent_doc_number] => 10022461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-17 [patent_title] => Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tangles [patent_app_type] => utility [patent_app_number] => 15/724402 [patent_app_country] => US [patent_app_date] => 2017-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 36736 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15724402 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/724402
Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tangles Oct 3, 2017 Issued
Array ( [id] => 12466974 [patent_doc_number] => 09987567 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-06-05 [patent_title] => Cannabinoid extraction process and system [patent_app_type] => utility [patent_app_number] => 15/721344 [patent_app_country] => US [patent_app_date] => 2017-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5561 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721344 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/721344
Cannabinoid extraction process and system Sep 28, 2017 Issued
Array ( [id] => 13763409 [patent_doc_number] => 10174039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-08 [patent_title] => P2X [patent_app_type] => utility [patent_app_number] => 15/717185 [patent_app_country] => US [patent_app_date] => 2017-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 32957 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15717185 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/717185
P2X Sep 26, 2017 Issued
Array ( [id] => 15209569 [patent_doc_number] => 20190367471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => PROCESS FOR PREPARING CYCLIC ESTERS FROM ALPHA-HYDROXY ESTERS AND CATALYSTS USED THEREIN [patent_app_type] => utility [patent_app_number] => 16/336014 [patent_app_country] => US [patent_app_date] => 2017-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11229 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336014 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/336014
Process for preparing cyclic esters from alpha-hydroxy esters and catalysts used therein Sep 24, 2017 Issued
Array ( [id] => 14581239 [patent_doc_number] => 20190218228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => ANTI-CANCER AGENTS AND PREPARATION THEREOF [patent_app_type] => utility [patent_app_number] => 16/335378 [patent_app_country] => US [patent_app_date] => 2017-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13897 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335378 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/335378
Anti-cancer agents and preparation thereof Sep 21, 2017 Issued
Array ( [id] => 13856297 [patent_doc_number] => 10189857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-29 [patent_title] => Positive allosteric modulators of the muscarinic acetylcholine receptor M [patent_app_type] => utility [patent_app_number] => 15/703451 [patent_app_country] => US [patent_app_date] => 2017-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18672 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703451 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/703451
Positive allosteric modulators of the muscarinic acetylcholine receptor M Sep 12, 2017 Issued
Array ( [id] => 13236969 [patent_doc_number] => 10131675 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-20 [patent_title] => Tricyclic DLK inhibitors and uses thereof [patent_app_type] => utility [patent_app_number] => 15/699095 [patent_app_country] => US [patent_app_date] => 2017-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44304 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 853 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699095 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/699095
Tricyclic DLK inhibitors and uses thereof Sep 7, 2017 Issued
Array ( [id] => 12606462 [patent_doc_number] => 20180093984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-05 [patent_title] => N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 15/698435 [patent_app_country] => US [patent_app_date] => 2017-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49537 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -54 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698435 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/698435
N-acyl amino acid compounds and methods of use Sep 6, 2017 Issued
Array ( [id] => 12857749 [patent_doc_number] => 20180177757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-28 [patent_title] => ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDS [patent_app_type] => utility [patent_app_number] => 15/698544 [patent_app_country] => US [patent_app_date] => 2017-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18349 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15698544 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/698544
Ultrapure tetrahydrocannabinol-11-oic acids Sep 6, 2017 Issued
Array ( [id] => 14926137 [patent_doc_number] => 20190298706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ANOREXIA NERVOSA AND BINGE EATING DISORDER [patent_app_type] => utility [patent_app_number] => 16/330469 [patent_app_country] => US [patent_app_date] => 2017-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42740 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330469 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/330469
Nonselective metabotropic glutamate receptor activators for treatment of anorexia nervosa and binge eating disorder Sep 5, 2017 Issued
Array ( [id] => 15383839 [patent_doc_number] => 10533091 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-14 [patent_title] => Color conversion with solid matrix films [patent_app_type] => utility [patent_app_number] => 15/691776 [patent_app_country] => US [patent_app_date] => 2017-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 115 [patent_no_of_words] => 46147 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 400 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15691776 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/691776
Color conversion with solid matrix films Aug 30, 2017 Issued
Array ( [id] => 12239867 [patent_doc_number] => 20180072730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'NOVEL 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 15/689136 [patent_app_country] => US [patent_app_date] => 2017-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 35802 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15689136 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/689136
7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection Aug 28, 2017 Issued
Array ( [id] => 13887675 [patent_doc_number] => 10196378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-05 [patent_title] => Inhibitors of BCR-ABL mutants and use thereof [patent_app_type] => utility [patent_app_number] => 15/685707 [patent_app_country] => US [patent_app_date] => 2017-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6137 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15685707 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/685707
Inhibitors of BCR-ABL mutants and use thereof Aug 23, 2017 Issued
Array ( [id] => 15948601 [patent_doc_number] => 10662189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-26 [patent_title] => PDE4 inhibitor [patent_app_type] => utility [patent_app_number] => 16/326976 [patent_app_country] => US [patent_app_date] => 2017-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30998 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326976 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/326976
PDE4 inhibitor Aug 21, 2017 Issued
Array ( [id] => 16321240 [patent_doc_number] => 10781196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-22 [patent_title] => Integrated process for direct saccharification and dehydration of intact biomass to furfurals [patent_app_type] => utility [patent_app_number] => 16/323000 [patent_app_country] => US [patent_app_date] => 2017-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 12 [patent_no_of_words] => 7311 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323000 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/323000
Integrated process for direct saccharification and dehydration of intact biomass to furfurals Aug 14, 2017 Issued
Array ( [id] => 13761257 [patent_doc_number] => 10172957 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-08 [patent_title] => Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents [patent_app_type] => utility [patent_app_number] => 15/675399 [patent_app_country] => US [patent_app_date] => 2017-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 11830 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15675399 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/675399
Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents Aug 10, 2017 Issued
Array ( [id] => 12975598 [patent_doc_number] => 20170340616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-30 [patent_title] => AMINOESTER DERIVATIVES [patent_app_type] => utility [patent_app_number] => 15/673710 [patent_app_country] => US [patent_app_date] => 2017-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 640 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673710 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/673710
Aminoester derivatives Aug 9, 2017 Issued
Menu